Efficacy Evaluation of Meropenem in Patients with Serious Community-acquired Pneumonia
- VernacularTitle:美罗培南治疗重症社区获得性肺炎临床疗效观察
- Author:
Hao XU
;
Jinghan JIANG
;
Ying WANG
- Publication Type:Journal Article
- Keywords:
Meropenem;
Serious community-acquired pneumonia;
Efficacy
- From:
Chinese Journal of Nosocomiology
2009;0(23):-
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE To investigate the efficacy of rneropenem for the meatment of the patients with serious community-acquired pneumonia(SCAP).METHODS Sixty-four patients with SCAP were randomly divided into two groups.Group A(the treatment group,41 cases) was treated with meropenem(5-1.0 g iv q8-12 h?7 d) and group B(the control group,23 cases) treated with mezlocillin(5-1.0 g iv q8-12 h?7 d) in an open clinical study.RESULTS The efficacy rate of group A was 85.0%,with a bacteria elimination rate of 86.4% wheveas 57.0% and 64.3% in group B.There were significant difference between two groups(P
